| There are two approved vaccines for the prevention | | | | eliminate the two main viruses that cause cancer? |
| of HPV infection with the two main cancer causing | | | | Early reports indicate that other strains that also |
| strains of the virus. Gardasil was first and was | | | | infect humans may become carcinogenic in |
| approved for use in women and girls ages 9-26. It is | | | | vaccinated women. Thus far the vaccine is unproven |
| only effective if you are not already HPV infected. | | | | in its effectiveness for men. |
| The trials of the vaccine on girls under age 12 was | | | | A recent report analyzing the scenario that must |
| for immune response only so it is unknown if the | | | | occur for the vaccine to be cost effective was done. |
| vaccine will actually be effective in that age group. | | | | The purpose of developing mathematical models is to |
| The actual clinical trails were conducted on women | | | | help policy makers decide if this is a cost effective |
| between ages 16 and 26. The drug was approved in | | | | method to treat an illness when little is known about |
| June 2006 but the end points of the first phase 3 | | | | how long it will do good and if perhaps it may do |
| trials were not reported until May 2007! The vaccine | | | | harm. The model being used now presumes life long |
| has been shown to prevent cervical lesions but it is | | | | immunity (no needed booster), the same effect on |
| unknown if it will actually prevent cervical cancer. | | | | girls 9-12 as on older women, no other strains of HPV |
| We do not know how long the vaccine confers | | | | causing any trouble, and that all vaccinated women |
| immunity. Will it be life long? If not, it is not as cost | | | | attend screening for cervical cancer just as they did |
| effective to vaccinate as it is to screen for cervical | | | | before vaccination. This chain of assumptions (and |
| cancer. It is well known that most infected women | | | | these are not all of them) was described by one |
| who become infected with HPV, clear the virus within | | | | author as "quite optimistic". In other words for it to |
| 2 years through normal immune function. | | | | be worth the cost of vaccination, all the assumptions |
| Another important point is, what happens when you | | | | must occur, a highly unlikely occurrence. |